Marco R Oggioni Selected Research

Marco R Oggioni Research Topics

Disease

10	Infections 01/2023 - 09/2004
6	Pneumonia (Pneumonitis) 10/2021 - 08/2003
3	Sepsis (Septicemia) 07/2016 - 12/2004
2	Pneumococcal Pneumonia 10/2021 - 09/2006
2	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 07/2020 - 09/2004
2	Brain Injuries (Brain Injury) 07/2020 - 12/2014
2	Meningococcal Meningitis 07/2020 - 12/2014
2	Pneumococcal Infections 12/2011 - 07/2003
2	Anthrax 06/2003 - 11/2002
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Liver Abscess 12/2021
1	COVID-19 06/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 06/2019
1	Cross Infection (Nosocomial Infection) 07/2016
1	Hemorrhage 12/2014
1	Fever (Fevers) 07/2009
1	Respiratory Tract Infections (Respiratory Tract Infection) 05/2009
1	Bacterial Pneumonia 05/2009
1	Meningitis 09/2004
1	Bacterial Meningitis 09/2004
1	Neoplasm Metastasis (Metastasis) 08/2003

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 09/2004 - 11/2002
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2006
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2021 - 06/2019
2	Matrix Metalloproteinases (MMPs)IBA 07/2020 - 12/2014
2	batimastat (BB 94)IBA 07/2020 - 12/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2004
2	Metalloproteases (Metalloproteinases)IBA 09/2006 - 08/2003
2	Peptides (Polypeptides)IBA 09/2006 - 12/2004
1	Capsules (Microcapsules)IBA 12/2021
1	MacrolidesIBA 10/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2020
1	Neuroprotective AgentsIBA 07/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2020
1	Matrix Metalloproteinase InhibitorsIBA 07/2020
1	benzoyl L-arginine methyl ester (BAME)IBA 06/2020
1	NucleotidesIBA 10/2019
1	DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA 10/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 06/2019
1	tazobactam drug combination ceftolozaneIBA 06/2019
1	ceftazidime drug combination avibactamIBA 06/2019
1	ChlorhexidineIBA 07/2016
1	CoagulaseIBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	CytokinesIBA 12/2011
1	Type V Secretion SystemsIBA 07/2009
1	Neuraminidase (Sialidase)IBA 05/2009
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2009
1	Complement System Proteins (Complement)IBA 09/2006
1	Streptococcus pneumoniae plY proteinIBA 09/2006
1	ZincIBA 08/2003
1	Peptide Hydrolases (Proteases)FDA Link 08/2003
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2003
1	Virulence Factors (Pathogenicity Factors)IBA 08/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2003
1	Immunoglobulin A (IgA)IBA 07/2003

Therapy/Procedure

3	Therapeutics 10/2021 - 09/2004
1	Baths 07/2016